Bruck Kifle

Array ( [id] => 1417756 [patent_doc_number] => 06509333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-21 [patent_title] => 'Lactams substituted by cyclic succinates as inhibitors of A protein production' [patent_app_type] => B2 [patent_app_number] => 09/871840 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49520 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2053 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509333.pdf [firstpage_image] =>[orig_patent_app_number] => 09871840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508500 [patent_doc_number] => 06441163 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents' [patent_app_type] => B1 [patent_app_number] => 09/867598 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8389 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441163.pdf [firstpage_image] =>[orig_patent_app_number] => 09867598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669477 [patent_doc_number] => 20030114461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => '1,4-Diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof' [patent_app_type] => new [patent_app_number] => 10/276647 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4571 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114461.pdf [firstpage_image] =>[orig_patent_app_number] => 10276647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706840 [patent_doc_number] => 20030153574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => '1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof' [patent_app_type] => new [patent_app_number] => 10/276646 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3587 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153574.pdf [firstpage_image] =>[orig_patent_app_number] => 10276646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319437 [patent_doc_number] => 06605613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Macrolides' [patent_app_type] => B2 [patent_app_number] => 09/866977 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4825 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605613.pdf [firstpage_image] =>[orig_patent_app_number] => 09866977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517568 [patent_doc_number] => 06500822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists' [patent_app_type] => B2 [patent_app_number] => 09/862522 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19165 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 511 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500822.pdf [firstpage_image] =>[orig_patent_app_number] => 09862522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658361 [patent_doc_number] => 07105509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Benzodiazepine derivatives as APP modulators' [patent_app_type] => utility [patent_app_number] => 10/296428 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45702 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105509.pdf [firstpage_image] =>[orig_patent_app_number] => 10296428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349874 [patent_doc_number] => 06579979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-17 [patent_title] => 'Treatment/purification of lactam media of reaction' [patent_app_type] => B2 [patent_app_number] => 09/860437 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579979.pdf [firstpage_image] =>[orig_patent_app_number] => 09860437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001051 [patent_doc_number] => 20010053776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Tricyclic pyridin-2-one analogue as a GABA receptor ligand' [patent_app_type] => new [patent_app_number] => 09/861318 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6563 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053776.pdf [firstpage_image] =>[orig_patent_app_number] => 09861318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740808 [patent_doc_number] => 20030158177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Melanin-concentrating hormone antagonist' [patent_app_type] => new [patent_app_number] => 10/276288 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64397 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158177.pdf [firstpage_image] =>[orig_patent_app_number] => 10276288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243134 [patent_doc_number] => 20020045609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Epothilone derivatives and methods for making and using the same' [patent_app_type] => new [patent_app_number] => 09/859085 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18746 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045609.pdf [firstpage_image] =>[orig_patent_app_number] => 09859085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1479558 [patent_doc_number] => 06452001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-09-17 [patent_title] => 'Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation' [patent_app_type] => B2 [patent_app_number] => 09/854885 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9408 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/452/06452001.pdf [firstpage_image] =>[orig_patent_app_number] => 09854885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363560 [patent_doc_number] => 06569867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-27 [patent_title] => 'Polyketide derivatives' [patent_app_type] => B2 [patent_app_number] => 09/853306 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18405 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569867.pdf [firstpage_image] =>[orig_patent_app_number] => 09853306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142453 [patent_doc_number] => 20020002280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Stabilized N-alkenyllactam' [patent_app_type] => new [patent_app_number] => 09/851346 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3323 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002280.pdf [firstpage_image] =>[orig_patent_app_number] => 09851346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520989 [patent_doc_number] => 06413954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors' [patent_app_type] => B1 [patent_app_number] => 09/850852 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11301 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413954.pdf [firstpage_image] =>[orig_patent_app_number] => 09850852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756560 [patent_doc_number] => 20030004337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Efficient lactam synthesis' [patent_app_type] => new [patent_app_number] => 09/848268 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9328 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004337.pdf [firstpage_image] =>[orig_patent_app_number] => 09848268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678937 [patent_doc_number] => 20030229078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Synthesis and use of thienotriazolodiazepines' [patent_app_type] => new [patent_app_number] => 10/258343 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10803 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229078.pdf [firstpage_image] =>[orig_patent_app_number] => 10258343 [rel_patent_id] =>[rel_patent_doc_number] =>)